Most Advanced Technology

Sepax®2 - fully automated cord blood processing system

(only available at Cordlife Singapore)

Stem cell isolation is a critical step in cord blood banking. It affects the number of stem cells that can be harvested or recovered from the cord blood. Cell recovery rates are critical because a higher number of stem cells could enhance the success of the transplant or treatment.

That's why Cordlife upgraded from processing cord blood manually to using a fully automated cord blood processing technology to help you maximize your investment. Cordlife is the only cord blood bank in Singapore that offers the world's most preferred fully automated cord blood processing technology, known as Sepax®2.

Sepax®2 is a Swiss-made and U.S. FDA-cleared device offers safe and sterile technology to recover as high as 99%* of stem cells* from cord blood. The system is functionally closed which ensures the sterility of the cord blood by eliminating exposure to air contaminants.

Main benefits of Sepax®2

  • Recovers as high as 99%1 of cells2 from cord blood; up to 52%3 higher than other processing methods
  • Consistently high yields, independent of operator skills
  • No sample mix up, only one cord blood unit per processing cycle
  • No cross contamination with other samples
  • Highly sterile

References
1Cordlife umbilical cord blood processing data as of 31 December 2010
2Total nucleated cell. 3Valeri et al., Transfusion 1996; 36: 303-8.

Sources: www.processedbysepax.com and Biosafe, manufacturer of Sepax® (figures accurate as of 17 November 2008).